---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-024265"
form_type: "8-K"
ticker: "ECOR"
cik: "0001560258"
company_name: "electroCore, Inc."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:39:23.059684+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# electroCore Q1 revenue $1.9M, up 58% YoY; net loss $5.6M

## Summary
- Net sales $1.9M, up 58% from Q1 2021 and 27% sequentially.
- GAAP net loss $5.6M; adjusted EBITDA net loss $4.6M.
- Cash and equivalents $29.9M at March 31, 2022; operating cash used $4.8M.
- Q2 2022 guidance: revenue at least $1.9M; cash used ~$3.5M.
- FDA Breakthrough Device for PTSD; exclusive Japan license with Teijin.

## SEC filing metadata
- accession: 0001213900-22-024265
- form_type: 8-K
- ticker: ECOR
- cik: 0001560258
- company_name: electroCore, Inc.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560258/000121390022024265/0001213900-22-024265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560258/000121390022024265/ecor-20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-024265
- JSON: https://secwatch.observer/filing/0001213900-22-024265.json
- Plain text: https://secwatch.observer/filing/0001213900-22-024265.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.